<div id="readability-page-1"><p>In a report released today, Albert Lowe from Craig-Hallum maintained a Buy rating on PMV Pharmaceuticals, with a price target of <span id="expert-recommendation-target">$4.00</span>.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>Lowe covers the Healthcare sector, focusing on stocks such as Rezolute, Atossa Therapeutics, and Eledon Pharmaceuticals. According to TipRanks, Lowe has an average return of <span>25.8%</span> and a 56.92% success rate on recommended stocks. </p> <p>PMV Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $5.00.</p></div>

PMVP

<p>Albert Lowe from Craig-Hallum maintains a Buy rating on PMV Pharmaceuticals (PMVP) with a $4.00 price target. Lowe, who covers the Healthcare sector, has an average return of 25.8% and a 56.92% success rate. PMV Pharmaceuticals has a Strong Buy consensus with a $5.00 price target.</p>

PMV Pharmaceuticals (PMVP) Receives a Buy from Craig-Hallum